AMLX - Amylyx Pharmaceuticals, Inc.
IEX Last Trade
4.01
-0.060 -1.496%
Share volume: 14,193
Last Updated: Thu 26 Dec 2024 08:30:32 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$4.07
-0.06
-1.47%
Summary score
25%
Profitability
17%
Dept financing
5%
Liquidity
75%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-13.57%
Return on assets
-8.61%
Return on sales
-2289.83%
Return on invested capital
88.96%
Total debt ratio
15.27%
Debt ratio change over timeo
-1.44%
Current Ratio
7.21%
Quick Ratio
6.98%
Cash Position Ratio
6.43%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-6.2%
Return on assets
1.51%
Return on sales
6.85%
Return on invested capital
-23.29%
Total debt ratio
15.92%
Debt ratio change over timeo
-1.32%
Current Ratio
6.58%
Quick Ratio
6.19%
Cash Position Ratio
5.49%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-36.62%
Return on assets
-2.8%
Return on sales
-13.16%
Return on invested capital
140.22%
Total debt ratio
22.28%
Debt ratio change over time
-2.38%
Current Ratio
4.48%
Quick Ratio
4.48%
Cash Position Ratio
4.07%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-51.69%
Return on assets
-76.45%
Return on sales
-1459.76%
Return on invested capital
-406.51%
Total debt ratio
-143.55%
Debt ratio change over time
-1.44%
Current Ratio
-23.13%
Quick Ratio
-22.61%
Cash Position Ratio
-21.02%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AMLX | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -13.57% | 18.83% | 17.34% | 7.6% |
| Return on assets | -8.61% | 4.16% | 8.21% | 3.22% |
| Return on sales | -2289.83% | 28.21% | 41.18% | 25.37% |
| Return on invested capital | 88.96% | 9.79% | -219.55% | 7.46% |
| Profitability | 25% | 58% | 73% | 37% |
| Total debt ratio | 15.27% | 82.89% | 55.88% | 60.02% |
| Debt ratio change over time | -1.44% | -4.38% | -0.73% | -33.74% |
| Dept financing | 5% | 25% | 42% | 18% |
| Current Ratio | 6.58% | 1.12% | 0% | 1.16% |
| Quick Ratio | 6.19% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 5.49% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 8% | 8% | 10% |
| Short-term ratios | AMLX | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -6.2% | 13.31% | 0% | 13.48% |
| Return on assets | 1.51% | 4.72% | 0% | 3.05% |
| Return on sales | 6.85% | 31.4% | 0% | 25.56% |
| Return on invested capital | -23.29% | 10.68% | 0% | 13.96% |
| Profitability | 13% | 94% | 0% | 87% |
| Total debt ratio | 15.92% | 80.89% | 0% | 59.04% |
| Debt ratio change over time | -1.32% | -41.82% | 0% | 7.13% |
| Dept financing | 5% | 25% | 0% | 43% |
| Current Ratio | 6.58% | 1.12% | 0% | 1.16% |
| Quick Ratio | 6.19% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 5.49% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 8% | 0% | 10% |